Stuttgart - Delayed Quote EUR
CytoDyn Inc (296.SG)
0.3200
+0.0480
+(17.65%)
At close: May 9 at 9:32:52 PM GMT+2
Breakdown
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
Operating Cash Flow
-4,752
-10,982
-25,110
-77,723
-117,573
Investing Cash Flow
0
0
0
0
-122
Financing Cash Flow
13,129
11,748
29,927
48,011
137,346
End Cash Position
16,400
9,814
9,048
4,231
33,943
Interest Paid Supplemental Data
26
45
19
63
147
Capital Expenditure
--
--
--
--
-122
Issuance of Capital Stock
3,441
9,137
25,786
41,195
1,000
Issuance of Debt
0
2,011
895
0
100,000
Repayment of Debt
--
--
--
0
-950
Free Cash Flow
-4,752
-10,982
-25,110
-77,723
-117,695
5/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVE.SW Evolva Holding SA
1.1000
-3.93%
RLFTF Relief Therapeutics Holding SA
2.5000
-3.47%
AARD Aardvark Therapeutics, Inc.
10.42
-2.89%
ATHE Alterity Therapeutics Limited
4.8000
+14.29%
ENZC Enzolytics, Inc.
0.0009
+12.50%
EYEN Eyenovia, Inc.
1.0800
-2.70%
CGTX Cognition Therapeutics, Inc.
0.3011
-8.76%
RYTM Rhythm Pharmaceuticals, Inc.
57.38
-5.50%
MDXG MiMedx Group, Inc.
7.05
-4.99%
ANNX Annexon, Inc.
1.6000
-5.88%